Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors

Podobne zapisy

• Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study
  od: Chen, Yung-Hsuan, i wsp.
  Wydane: (2019)
• Real‐World Data on Prognostic Factors for Overall Survival in EGFR Mutation‐Positive Advanced Non‐Small Cell Lung Cancer Patients Treated with First‐Line Gefitinib
  od: Yao, Zong‐Han, i wsp.
  Wydane: (2017)
• Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases
  od: Yang, T. Jonathan, i wsp.
  Wydane: (2016)
• Combination of Whole-Brain Radiotherapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases
  od: Chien-Hung Chen, i wsp.
  Wydane: (2019-07-01)
• The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
  od: Wu, Shang-Gin, i wsp.
  Wydane: (2020)